ACM
TNDM icon

Anfield Capital Management’s Tandem Diabetes Care TNDM Stock Holding History

Anfield Capital Management’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-73
Closed -$2.58K – 527
2024
Q1 		$2.58K Buy
+73
New +$1.96K ﹤0.01% 238
2020
Q1 		– Sell
-286
Closed -$17K – 358
2019
Q4 		$17K Buy
+286
New +$17.6K 0.01% 287

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Anfield Capital Management's TNDM Position: Q2 2024 in Review

Anfield Capital Management sold out of Tandem Diabetes Care (TNDM) in Q2 2024, closing a stake of 73 shares — an estimated $2.58K sold.

Anfield Capital Management first reported a position in TNDM in Q4 2019 and held it in 2 quarters. The position peaked at $17K in Q4 2019. 317 funds tracked by Wall St. Rank hold TNDM as of Q2 2024.

  • Anfield Capital Management reported no remaining Tandem Diabetes Care position as of Q2 2024 after selling out during the quarter.
  • Anfield Capital Management sold 73 Tandem Diabetes Care shares in Q2 2024, an estimated $2.58K.
  • Anfield Capital Management first reported a position in Tandem Diabetes Care in Q4 2019 and held it in 2 quarters.
  • Anfield Capital Management's Tandem Diabetes Care position peaked at $17K in Q4 2019.
  • 317 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2024.

Based on Anfield Capital Management's 13F filing for Q2 2024, filed 31 Jul 2024.